EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma

被引:0
|
作者
Alexander J. J. Smits
J. Alain Kummer
John W. J. Hinrichs
Gerarda J. M. Herder
Karen C. Scheidel-Jacobse
N. Mehdi Jiwa
T. Emiel G. Ruijter
Peet T. G. A. Nooijen
Monica G. Looijen-Salamon
Marjolijn J. L. Ligtenberg
Frederik B. Thunnissen
Daniëlle A. M. Heideman
Roel A. de Weger
Aryan Vink
机构
[1] St. Antonius Hospital,Department of Pathology
[2] University Medical Center Utrecht,Department of Pathology
[3] St. Antonius Hospital,Department of Pulmonary Diseases
[4] Medical Center Alkmaar,Department of Pathology
[5] Rijnstate Hospital,Department of Pathology
[6] Jeroen Bosch Hospital,Department of Pathology
[7] Radboud University Nijmegen Medical Centre,Department of Pathology
[8] VU University Medical Center,Department of Pathology
来源
Cellular Oncology | 2012年 / 35卷
关键词
Non-small cell lung cancer; Adenocarcinoma; Metastasis; Pleural effusion;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:189 / 196
页数:7
相关论文
共 50 条
  • [1] EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma
    Smits, Alexander J. J.
    Kummer, J. Alain
    Hinrichs, John W. J.
    Herder, Gerarda J. M.
    Scheidel-Jacobse, Karen C.
    Jiwa, N. Mehdi
    Ruijter, T. Emiel G.
    Nooijen, Peet T. G. A.
    Looijen-Salamon, Monica G.
    Ligtenberg, Marjolijn J. L.
    Thunnissen, Frederik B.
    Heideman, Danielle A. M.
    de Weger, Roel A.
    Vink, Aryan
    CELLULAR ONCOLOGY, 2012, 35 (03) : 189 - 196
  • [2] EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors
    Yang, Jiyoul
    Lee, Ok-Jun
    Son, Seung-Myoung
    Woo, Chang Gok
    Jeong, Yusook
    Yang, Yaewon
    Kwon, Jihyun
    Lee, Ki Hyeong
    Han, Hye Sook
    CANCER RESEARCH AND TREATMENT, 2018, 50 (03): : 908 - 916
  • [3] KRAS and EGFR mutations coexisting in lung adenocarcinoma
    Vitor Sousa
    Ana Alarcão
    Patricia Couceiro
    Maria R Silva
    Maria J d’Aguiar
    Lia Teixeira
    Lina Carvalho
    BMC Proceedings, 4 (Suppl 2)
  • [4] RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer
    Tsai, T-H.
    Su, K-Y.
    Wu, S-G.
    Chang, Y-L.
    Luo, S-C.
    Jan, I-S.
    Yu, C-J.
    Yu, S-L.
    Shih, J-Y.
    Yang, P-C.
    EUROPEAN RESPIRATORY JOURNAL, 2012, 39 (03) : 677 - 684
  • [5] Comparison of EGFR mutation rates in lung adenocarcinoma tissue and pleural effusion samples
    Guan, Y.
    Wang, Z. J.
    Wang, L. Q.
    Hua, D. F.
    Liu, J.
    GENETICS AND MOLECULAR RESEARCH, 2016, 15 (02)
  • [6] Analysis of EGFR mutation status in malignant pleural effusion and plasma from patients with advanced lung adenocarcinoma
    Son, Seung-Myoung
    Woo, Chang Gok
    Han, Hye Sook
    Lee, Ki Hyeong
    Lim, Young Hyun
    Lee, Ok-Jun
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (09) : 1547 - 1555
  • [7] Pleural Fluid EGFR Mutation Testing in 10 Patients with Advanced Lung Adenocarcinoma with Pleural Effusion
    Kim, Y.
    Lee, Y. J.
    Ha, J. H.
    Hong, Y. J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S518 - S519
  • [8] Black pleural effusion in a patient with EGFR-positive lung adenocarcinoma
    Issaris, Vasileios
    Kotsifas, Konstantinos
    Lazarou, Vasiliki
    Giosdekou, Natalia
    Poupouzas, Georgios
    Athanasiou, Nikolaos
    Giannikos, Georgios
    Kompogiorgas, Steven
    Milas, Gerasimos-Panagiotis
    Balis, Evangelos
    PNEUMON, 2023,
  • [9] EGFR mutations in malignant pleural effusion of non-small cell lung cancer:: A case report
    Huang, MJ
    Lim, KH
    Tzen, CY
    Hsu, HS
    Yen, Y
    Huang, BS
    LUNG CANCER, 2005, 49 (03) : 413 - 415
  • [10] Complex EGFR Mutations in Lung Adenocarcinoma
    Wu, S.
    Yu, C.
    Yang, J. C.
    Shih, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S233 - S234